Stay up to date on recent advances in the multidisciplinary approach to cancer.
Cretostimogene Grenadenorepvec Displays Efficacy in BCG-Unresponsive NMIBC
Complete response rates were observed consistently across patient subgroups in those with high-risk BCG-unresponsive non-muscle invasive bladder cancer.
Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors
A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.
Investigators Discontinue Trial Assessing Capivasertib in Metastatic CRPC
A recommendation from an independent data monitoring committee prompted the discontinuation of the phase 3 CAPItello-280 trial.
Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.
Surgical Overtreatment Has Declined in Grade Group 1 Prostate Cancer
Data show that patients who undergo grade group 1 prostatectomies may experience an increased likelihood of higher risk features.
Outpatient Robotic Partial Nephrectomy Is Safe/Feasible for Renal Tumors
A prospective trial established that 97% of patients were successfully discharged on the same day as receiving robotic partial nephrectomy.
